Glutathione is an antioxidant your cells make from three amino acids, and creams containing it are sold across India for skin lightening. The evidence rests on five small trials of 21 to 30 people; the best of them found a modest, temporary drop in melanin with a 2% lotion. The real risks come from what else is mixed into 'whitening' creams and from injections, which CDSCO's May 2026 notice says no cosmetic may be given as.
What is glutathione?
Glutathione is a tripeptide, a small protein fragment that every cell in the body makes from three amino acids: glutamate, cysteine and glycine. The 2016 review in the Indian Journal of Dermatology, Venereology and Leprology (Sonthalia, Daulatabad and Sarkar) explains that its active sulphydryl group comes from cysteine, and that it exists in a reduced form (GSH) and an oxidised form (GSSG). Its day job is to keep the inside of cells in redox balance, neutralising reactive oxygen species.
The skin-lightening claim rests on what glutathione does to tyrosinase, the enzyme that makes melanin. The IJDVL authors list three routes: direct chelation of the copper site of tyrosinase, interference with the transfer of tyrosinase into premelanosomes, and an indirect antioxidant effect. Glutathione also shifts melanin production from the dark eumelanin towards the lighter, reddish phaeomelanin.
The chemistry has a catch. A 2018 review in Dermatology Practical & Conceptual (Sonthalia et al.) notes that glutathione may not enter melanosomes well, and that in cell studies an esterified form inhibited tyrosinase where plain glutathione did not; the authors say these results need further validation. A mechanism that works in a test tube is not proof that a cream works on a face, which is why the trials matter more than the biochemistry.
Does glutathione cream actually lighten skin?
Slightly, temporarily, and on the evidence of very small trials. A systematic review published in September 2025 in the Journal of Clinical and Aesthetic Dermatology (Khanna, Rambhia and Chapas) searched PubMed and MEDLINE, screened 446 articles and found only five clinical trials of topical glutathione. The largest had 30 participants and the smallest 21.
The trial most often quoted is Watanabe et al. in the Philippines: 30 healthy women aged 30 to 50 applied 2% oxidised glutathione (GSSG) lotion to one side of the face and a placebo to the other, twice daily for 10 weeks. The melanin index on the treated side fell from 272.77 to 243.47 at week 10, a statistically significant change of roughly a tenth. The 2018 Dermatology Practical & Conceptual review adds the detail the marketing leaves out: the whitening was temporary.
The 2025 review's verdict is that topical glutathione 'shows promise' but that 'conclusions that can be drawn from the included studies are significantly limited', with a lack of control groups, and that further randomised controlled trials are necessary. The IJDVL review reached the same point in 2016: 'As of now, there is a lack of robust evidence in favour of glutathione for the treatment of hyperpigmentation.' Nine years and no larger trial later, that sentence still stands.
What did the five trials of topical glutathione find?
Two of the five measured skin pigment, and only one of those compared the cream with a placebo. The rest looked at sun sensitivity, oxidative stress or rosacea. The table is drawn from the 2025 systematic review.
| Trial | People | Product | Length | Main result |
|---|---|---|---|---|
| Watanabe et al., Philippines | 30 | 2% GSSG lotion, split-face vs placebo | 10 weeks | melanin index 272.77 to 243.47 |
| Jung et al., South Korea | 24 | multi-ingredient cream with 2% glutathione disulfide, no comparator | 8 weeks | significant melanin index fall |
| Grandi et al., Italy | 30 | 2% S-acyl glutathione cream vs placebo | up to 10 weeks | higher minimal erythema dose (135 vs 105 J/cm²) |
| Cui et al., China | 21 | glutathione precursor blend vs placebo | up to 12 weeks | better GSH/GSSG ratio after UV |
| Dall'Oglio et al., Italy | 30 | 0.1% GSH-C4 with azelaic acid, for rosacea | 8 weeks | fewer inflammatory papules |
Three things follow. First, the Jung cream mixed glutathione with other actives and had no comparison group, so its melanin result cannot be credited to glutathione. Second, the Grandi and Cui trials say something about sun damage, not about complexion. Third, every trial stopped at 8 to 12 weeks, so nobody knows what a year of use does. Acne, wrinkle-removal and 'glow' claims printed on Indian packaging were not tested in any of them.
How does the cream compare with tablets and injections?
Creams and tablets have small trials and mild side effects; injections have no sound trial and serious reported harms. The 2018 review describes two oral trials: 60 Thai students took 500 mg a day for 4 weeks (melanin index fell at 2 of 6 sites) and 30 Filipino women took a 500 mg lozenge for 8 weeks (90% rated the lightening moderate). Both were short, with no follow-up, and the IJDVL review says oral bioavailability is disputed.
For IV glutathione the IJDVL review found not a single trial for skin lightening, while manufacturers suggested 600 to 1,200 mg once or twice a week. The one study since, Zubair et al. in Pakistan (1,200 mg twice weekly for 6 weeks), saw liver dysfunction in 32% of treated patients and one anaphylactic shock, with any benefit gone by 4 to 6 months (2018 review; Cureus 2025). CDSCO approved IV glutathione only for liver conditions (2018 review).
| Route | Trial evidence | Reported harms |
|---|---|---|
| Cream or lotion, 2% | 5 trials of 21 to 30 people; modest, temporary lightening | one case of mild redness for two days |
| Tablet or lozenge, 500 mg a day | 2 small trials of 4 to 8 weeks | well tolerated; bioavailability disputed |
| IV drip, 600 to 1,200 mg | 1 flawed study | liver dysfunction in 32%, anaphylaxis; Philippine FDA reports of severe skin reactions, kidney and thyroid harm |
A 2019 US FDA alert adds contamination to the list: seven clinic patients reacted within minutes to compounded IV glutathione made from powder holding up to five times the endotoxin limit.
Is glutathione cream safe, and what else is in 'whitening' creams?
Glutathione itself was well tolerated in the trials; the danger in India is the rest of the tube. In the Watanabe trial one of 30 women had mild redness on days 2 and 3 that cleared by day 4, and the Jung trial reported no adverse events (2025 review). The review still says safety data are limited.
Steroids are the big problem. A 2026 cross-sectional study in Cureus (Sethi et al.) from a government medical college in western Uttar Pradesh examined 96 consecutive patients with topical steroid-damaged face. 95.8% did not know what their cream contained and 97.9% had never read the leaflet. 64.6% had used it without any prescription, most often on a pharmacist's suggestion. The commonest steroid was clobetasol propionate (44.8%), a super-potent class I steroid, used for a mean of 13.65 months, usually for melasma (40.6%), fungal infection or acne. The damage: patchy loss of pigment and skin thinning in 87.5%, unwanted facial hair in 71.9%, acne-like eruptions and visible blood vessels in 63.5% each.
Hydroquinone is the second. The US FDA states there are no FDA-approved or legally marketed over-the-counter skin-lightening products, that hydroquinone products have caused rashes, facial swelling and ochronosis (a discolouration that may be permanent), and that the only approved hydroquinone product is a prescription melasma cream for short-term use.
Heavy metals are the third. On 8 September 2026 CDSCO named two imported whitening creams, Goree Beauty Cream and Chandni Whitening Cream, as unauthorised and containing heavy metals beyond the specified limits, with possible toxic effects.
What does Indian law say about glutathione for skin whitening?
CDSCO's position is that cosmetics are for external use only: they cannot be injected and cannot be used for treatment. The public notice of 18 May 2026 (File No. COS-12/1/2026-eoffice), signed by the Drugs Controller General (India), quotes the Drugs and Cosmetics Act, 1940 definition of a cosmetic as an article 'intended to be rubbed, poured, sprinkled or sprayed on' the body. It states that products supplied as injectable preparations do not fall under the definition of cosmetics, that no cosmetic is permitted to be used as an injection by consumers, professionals or aesthetic clinics, and that no cosmetic is permitted to be used in treatment. Prohibited ingredients, misleading label claims, use for treatment and injection all attract action under the Act and the Cosmetics Rules, 2020. The Bureau of Indian Standards publishes the list of ingredients generally not recognised as safe (GNRAS). Violations can be reported to cosmetics@cdsco.nic.in or the State Licensing Authority.
What that means for the three forms:
- A glutathione cream is a legal cosmetic if it is licensed as one, carries a manufacturing licence number, batch and expiry, and makes no treatment claims.
- Oral glutathione is sold over the counter in India, the IJDVL review notes, and patients often self-medicate on manufacturer claims.
- A glutathione 'glow drip' in a salon or clinic falls outside the cosmetic definition; the only CDSCO-approved IV indications are liver conditions (2018 review).
The IJDVL authors wrote in 2016 that a statutory ban on IV glutathione for skin 'remains elusive'; the 2026 notice is the clearest statement since.
How should you choose and use a skin-lightening product?
Start with a dermatologist, not a pharmacy counter. A dermatologist can name the cause; melasma was why 40.6% of the steroid-damaged patients in the Uttar Pradesh study had started a cream.
A checklist drawn from the sources:
- Buy only products showing a manufacturing licence number, manufacturer's details, batch number, dates of manufacture and expiry, and a registration number if imported (CDSCO alert, September 2026).
- Read the ingredient list. Avoid clobetasol, betamethasone, mometasone or any other corticosteroid, hydroquinone, and any product with no ingredient list.
- Treat a 2% glutathione cream as a modest, temporary brightener that took 8 to 10 weeks to show a measurable change in the trials.
- Refuse injections of any cosmetic, and report a clinic offering them to cosmetics@cdsco.nic.in.
Stop the cream and see a dermatologist if you notice new acne, visible thread veins, thinning skin, unwanted facial hair, or patches lighter or darker than before. See a doctor the same day if a rash spreads or the face swells. Call 112 or go to the nearest hospital emergency department if anyone has chills, vomiting, low blood pressure or difficulty breathing within minutes to hours of a glutathione injection.
The lightening in the trials faded once the lotion stopped, so budget for indefinite use or decide the small change is not worth it. A general physician can refer a damaged face, but a dermatologist is the right specialist. This guide is general information from the sources listed below, not medical advice; a registered doctor makes decisions with you.
